Business Wire

FRAMINGHAM, Mass.--(BUSINESS WIRE)-- Staples, Inc. (the “Company”) today announced the early exchange results of the previously announced offer to exchange (the “Exchange Offer”) any and all of the Company’s outstanding 10.75% Senior Notes due 2027 (the “Old Notes”) held by Eligible Holders (as defined below) for newly issued 12.75% Junior Lien Secured Notes due 2030 (the “Exchange Notes” and the issuance thereof, the “Exchange Notes Issuance”)... (continue reading...)

FARMINGTON, Utah--(BUSINESS WIRE)-- PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”) announced today that subsidiaries of the Company have agreed to acquire the operations of 53 skilled nursing and assisted/independent living facilities across 8 western states. The facilities are currently operated by Prestige, a family company whose legacy of caring for seniors dates back to the 1940s.

The operations are located in 8 states, including Oregon (21... (continue reading...)

Daily nonstop seasonal service from New York to Edinburgh introduces the airline’s award-winning Mint® and Core product offerings to its fifth transatlantic market

To celebrate launch, limited roundtrip fares starting at £399 and $499 in Core and £1999 and $2999 in Mint Available

NEW YORK--(BUSINESS WIRE)-- JetBlue (Nasdaq: JBLU) announced it has expanded its transatlantic offerings with new, nonstop flights to Edinburgh taking off from New York today.... (continue reading...)

DALLAS--(BUSINESS WIRE)-- Copart, Inc. (NASDAQ: CPRT) announced today that Leah Stearns, the company’s Chief Financial Officer, will participate in a fireside chat at Baird’s Global Consumer, Technology & Services Conference on Thursday, June 6, 2024. The presentation is scheduled for 10:15 am Eastern Time.

A live audio webcast of the presentation will be accessible via the Investor Relations section of the company’s website at ... (continue reading...)

LOS ANGELES--(BUSINESS WIRE)-- Turn Therapeutics, an innovative biotech company, launched its first public investment campaign today to fund clinical trials of its Food and Drug Administration-cleared antimicrobial ointment for two potential new drug indications: moderate to severe eczema and onychomycosis, or toenail fungus.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240522215556/en/

This public... (continue reading...)